Living with Essential Thrombocythemia (ET)? You May Be Eligible for a Clinical Trial

You may be eligible for a clinical trial evaluating an investigational oral treatment for adults whose ET is no longer responding to, or cannot tolerate, hydroxyurea (hydroxycarbamide).

By participating, you may help advance research while receiving study-related care and close medical monitoring throughout the trial.

Interested in participating?

Contact our research team today to learn more and find out if you may qualify.